Acetylcholinesterase: a primary target for drugs and insecticides

S Thapa, M Lv, H Xu - Mini reviews in medicinal chemistry, 2017 - ingentaconnect.com
Background: Acetylcholinesterase is a serine hydrolase that terminates the action of the
neurotransmitter acetylcholine by hydrolyzing it into acetic acid and choline. Objective: The …

Advances in screening assays for identifying cholinesterase ligands

PCO de Oliveira, LW Tinoco, CL Cardoso… - TrAC Trends in …, 2023 - Elsevier
Acetylcholinesterase and butyrylcholinesterase are the two enzymes involved in the
cholinergic system and its modulation. These enzymes have been recognized as …

In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease

V Kumar, A Saha, K Roy - Computational Biology and Chemistry, 2020 - Elsevier
In this research, we have implemented two-dimensional quantitative structure-activity
relationship (2D-QSAR) modeling using two different datasets, namely, acetylcholinesterase …

[PDF][PDF] In silico study of coumarins derivatives with potential use in systemic diseases

A Carrasco-Carballo… - … Res. Appl. Chem, 2022 - biointerfaceresearch.com
Coumarins have been widely used in various human systemic diseases; however, their
molecular action is not known in many cases. In silico studies are an option to explore the …

[HTML][HTML] Synthesis, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities, and molecular docking studies of a novel compound based on …

A Asghar, M Yousuf, G Fareed, R Nazir, A Hassan… - RSC …, 2020 - pubs.rsc.org
Synthesis of a compound with balanced bioactivities against a specific target is always a
challenging task. In this study, a novel compound (1) has been synthesized by combination …

[HTML][HTML] Phytosterol-rich compressed fluids extracts from Phormidium autumnale cyanobacteria with neuroprotective potential

MB Fagundes, G Alvarez-Rivera, JA Mendiola… - Algal Research, 2021 - Elsevier
Phormidium autumnale (P. autumnale) is a cyanobacteria with an unknown metabolic
system, since only few studies have been reported. Among the produced metabolites …

Design, facile synthesis, and evaluation of novel spiro-and pyrazolo [1, 5-c] quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies

J Gálvez, S Polo, B Insuasty, M Gutiérrez… - … Biology and Chemistry, 2018 - Elsevier
Given the wide spectrum of biological uses of pyrazolo [1, 5-c] quinazoline and spiro-
quinazoline derivatives as anticancer, anti-inflammatory analgesic agents, and their …

Synthesis, in vitro and docking studies of 2-substituted 5, 6, 7, 8-tetrahydrobenzo [4, 5] thieno [2, 3-d] pyrimidine-4 (3H)-one derivatives as agents for the treatment of …

AS Chiriapkin, IP Kodonidi, DI Pozdnyakov… - Chimica Techno …, 2022 - journals.urfu.ru
Alzheimer's disease is a chronic neurodegenerative disease, which is characterized mainly
by a progressive decrease in intellectual abilities, memory impairment and a change in a …

Advanced analytical methodologies in Alzheimer's disease drug discovery

A De Simone, M Naldi, D Tedesco, M Bartolini… - … of Pharmaceutical and …, 2020 - Elsevier
Despite the constant progress in the understanding of the etiopathogenesis of Alzheimer's
disease (AD) over the last 50 years, just four long-standing drugs are currently used for AD …

Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR)

P Bacalhau, AA San Juan, A Goth, AT Caldeira… - Bioorganic …, 2016 - Elsevier
Rivastigmine is a very important drug prescribed for the treatment of Alzheimer's disease
(AD) symptoms. It is a dual inhibitor, in that it inhibits both acetylcholinesterase (AChE) and …